Technetium-99m TRODAT-1, a tropane derivative, has shown promise as a
tracer for the imaging of dopamine transporters in preliminary studies
in rats and baboons. The present report concerns the first study of t
he use of [Tc-99m]TRODAT-1 for the same purpose in humans. The specifi
c uptake of [Tc-99m]TRODAT-1 in dopamine transporter sites located in
the basal ganglia area was confirmed: the best contrast between the ba
sal ganglia and the occipital area, which is devoid of dopamine transp
orters, was achieved at 120-140 min following injection. The developme
nt of a Tc-99m-based agent bypasses the need for cyclotron-produced ra
dionuclides, which will be of benefit for routine clinical studies.